This study demonstrated that the SA/CS double-layer wall material system effectively improved the encapsulation efficiency, structural stability, and intestinal release behavior of SCP gel beads.
Abstract
Sea cucumber mouthpart peptides (SCPs) are marine bioactive peptides with considerable application potential. However, their oral delivery remains challenging because of their poor stability and low intestinal bioavailability. To develop a delivery system for SCPs with gastric protection and pH-responsive intestinal sustained-release properties, double-layer gel beads (SCP-BMs) were fabricated through ionic gelation, with SCPs as the core material and sodium alginate (SA) and chitosan (CS) as the wall materials. The preparation conditions of the gel beads were optimized using single-factor experiments and response surface methodology (RSM). The optimized gel beads were then characterized for their morphology, thermal stability, in vitro gastrointestinal release behavior, and antioxidant activity. The results showed that the optimal preparation conditions were 1.67% (w/v) sodium alginate, 0.96% (w/v) chitosan, and 2.16% (w/v) CaCl2. Under the optimized conditions, the encapsulation efficiency (EE) reached 94.33%, significantly higher than that of the single-layer gel beads (SCP-SMs, 58.61%). Structural characterization showed that SCP-BMs exhibited a more compact structure than SCP-SMs, along with improved thermal stability. In vitro release and antioxidant assays demonstrated that SCP-BMs exhibited better gastric protection, pH-responsive intestinal release, and higher 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS) radical scavenging activity compared with SCP-SMs. This study demonstrated that the SA/CS double-layer wall material system effectively improved the encapsulation efficiency, structural stability, and intestinal release behavior of SCP gel beads. These findings provide a feasible strategy for the development of SCP delivery systems and offer a theoretical basis for the high-value utilization of sea cucumber byproducts.
Naringenin has gastrointestinal pharmacological potential, but poor aqueous solubility, rapid crystallization and limited intestinal residence constrain oral formulation performance. This study evaluated whether coupled tripolyphosphate (TPP) and calcium-ion gelation could produce chitosan/sodium alginate (CS/ALG) nano...
Shuai Yan, Jiu-Ba Zhang, Lian-Lin Su et al.· RSC Advances· 0 citations
The results demonstrated the successful preparation of EA-encapsulated nanoparticles with favorable physicochemical properties, sustained release, favourable initial colloidal properties, and enhanced gastrointestinal stability, supporting their future applications in food and nutraceutical formulations.
Sanjay Gowda, R. P. Singh, Asha Martin· Food Biophysics· 0 citations
This study explored the microencapsulation of mandarin (Citrus reticulata) peel extract using ionic gelation and freeze-drying to improve the stability and bioavailability of citrus bioactives. Encapsulation involved sodium alginate, maltodextrin (MD), gum arabic (GA), and Aloe vera gel powder (0.3%), with a 20:80 core...
Ankit Kumar, Chaman Kumar, P. S. Rao et al.· Preparative Biochemistry & B...· 0 citations
: To address the intrinsic drawbacks of pure drug-loaded chitosan hydrogels—namely poor mechanical strength, severe initial burst release, and insufficient structural stability—this work developed a multi-walled carbon nanotube (MWCNT)/chitosan composite hydrogel loaded with Panax notoginseng leaf saponins (LPNS). Syst...
Fu-Neng Tan· Academic Journal of Material...· 0 citations
Fucoxanthin (FX), a hydrophobic marine carotenoid, exhibits low stability and oral bioavailability under harsh conditions. A pH-responsive sodium alginate-xanthan gum (SA/XG) hydrogel incorporating soy protein nanoparticles (SPN) was fabricated for FX stabilization and intestinal-targeted release. SA/XG ratio and inter...
The developed chitosan-coated Eudragit® S100 nanoparticle system represents a promising platform for sustained, colon-targeted oral delivery of HSP and other poorly bioavailable bioactive compounds.